Abstract 1841: Investigating mechanisms of tumor eradication by blocking SIAH E3 ligase, a major tumor vulnerability, in EGFR/RAS-driven human cancer
Jonathan M. Baker(Old Dominion University), Amy Tang(University of Southern California), Julia Wulfkuhle(University of California, San Francisco), Andrew Howell(Old Dominion University), Rosa I. Gallagher(George Mason University), Natalie Stahr(Eastern Virginia Medical School), Ashleigh Hannah(Old Dominion University), Emanuel F. Petricoin(Center for Biologics Evaluation and Research)
Cited by 0
Related Papers
Overall survival in patients with pancreatic cancer receiving matched therapies following molecular profiling: a retrospective analysis of the Know Your Tumor registry trial
|The Lancet Oncology|2020|541
Redefining breast cancer subtypes to guide treatment prioritization and maximize response: Predictive biomarkers across 10 cancer therapies
|Cancer Cell|2022|335
Durvalumab with olaparib and paclitaxel for high-risk HER2-negative stage II/III breast cancer: Results from the adaptively randomized I-SPY2 trial
|Cancer Cell|2021|330